<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Delivery or Development?</title>
	<atom:link href="http://blog.pharmtech.com/2008/03/27/delivery-or-development/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2008/03/27/delivery-or-development/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Thu, 09 May 2013 23:30:55 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Rx</title>
		<link>http://blog.pharmtech.com/2008/03/27/delivery-or-development/comment-page-1/#comment-30627</link>
		<dc:creator>Rx</dc:creator>
		<pubDate>Fri, 18 Jun 2010 16:59:18 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=52#comment-30627</guid>
		<description>I agree too. Introducing new delivery methods is just a temp solution. The real solution would be to introduce new chemical or biological entities.</description>
		<content:encoded><![CDATA[<p>I agree too. Introducing new delivery methods is just a temp solution. The real solution would be to introduce new chemical or biological entities.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Interested in Drug Delivery</title>
		<link>http://blog.pharmtech.com/2008/03/27/delivery-or-development/comment-page-1/#comment-17845</link>
		<dc:creator>Interested in Drug Delivery</dc:creator>
		<pubDate>Fri, 24 Jul 2009 21:52:30 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=52#comment-17845</guid>
		<description>I couldn&#039;t agree more. It&#039;s interesting to see pharma companies introducing new delivery methods, but they can&#039;t solely rely on this type of innovation if they want to remain competitive in the pharmaceutical industry. They need to go back to the drawing board, and set their efforts to creating new drugs in order to considered innovative.</description>
		<content:encoded><![CDATA[<p>I couldn&#8217;t agree more. It&#8217;s interesting to see pharma companies introducing new delivery methods, but they can&#8217;t solely rely on this type of innovation if they want to remain competitive in the pharmaceutical industry. They need to go back to the drawing board, and set their efforts to creating new drugs in order to considered innovative.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
